These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 26491894)

  • 41. Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology.
    Miles K; McQueen L; Ngai S; Law P
    Cancer Imaging; 2015 Nov; 15():18. PubMed ID: 26578188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
    Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
    J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New challenges and perspectives in nuclear medicine imaging].
    Borbély K
    Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron Emission Tomography (PET) and breast cancer in clinical practice.
    Lavayssière R; Cabée AE; Filmont JE
    Eur J Radiol; 2009 Jan; 69(1):50-8. PubMed ID: 18814983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET.
    Koo PJ; Kwak JJ; Pokharel S; Choyke PL
    Curr Oncol Rep; 2015 Dec; 17(12):56. PubMed ID: 26462919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous PET/MRI vs PET/CT in oncology. A systematic review.
    Riola-Parada C; García-Cañamaque L; Pérez-Dueñas V; Garcerant-Tafur M; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):306-12. PubMed ID: 27424217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).
    Nensa F; Bamberg F; Rischpler C; Menezes L; Poeppel TD; la Fougère C; Beitzke D; Rasul S; Loewe C; Nikolaou K; Bucerius J; Kjaer A; Gutberlet M; Prakken NH; Vliegenthart R; Slart RHJA; Nekolla SG; Lassen ML; Pichler BJ; Schlosser T; Jacquier A; Quick HH; Schäfers M; Hacker M; ;
    Eur Radiol; 2018 Oct; 28(10):4086-4101. PubMed ID: 29717368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
    Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
    J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric Oncologic Imaging: A Key Application of Combined PET/MRI.
    Gatidis S; la Fougère C; Schaefer JF
    Rofo; 2016 Apr; 188(4):359-64. PubMed ID: 27002497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.
    Voss SD
    Pediatr Radiol; 2023 Jun; 53(7):1443-1453. PubMed ID: 36899268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET/MRI in cancer patients: first experiences and vision from Copenhagen.
    Kjær A; Loft A; Law I; Berthelsen AK; Borgwardt L; Löfgren J; Johnbeck CB; Hansen AE; Keller S; Holm S; Højgaard L
    MAGMA; 2013 Feb; 26(1):37-47. PubMed ID: 23266511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Emerging Role of PET/MR Imaging in Gynecologic Cancers.
    Ponisio MR; Fowler KJ; Dehdashti F
    PET Clin; 2016 Oct; 11(4):425-40. PubMed ID: 27593247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
    Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
    Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.